Accelerating and de-risking medical device development with digital patient twins
Virtonomy introduces v-Patients, enabling medical device developers to perform development and testing in a virtual environment, thereby accelerating development, reducing risks, expenses, and regulatory burden. Our end-to-end digital twin and simulation solution is based on an ever-expanding database of real clinical data to reflect anatomical variability, demographic diversity and pathological conditions.
Trusted by
We cover a wide range of medical devices
Heart valves
Anticipate anatomical and positional changes during the cardiac cycle, significantly reducing the risk of implant failure.
TAH and Heart Assist Devices
Simulate blood flow dynamics, anatomical variations, and long-term device performance, ensuring optimal fit and function.
Occluders
Pre-test device deployment, positioning, and stability, ensuring effective closure and minimizing risks of migration or residual shunts.
Catheters
Simulate navigation through complex vascular pathways and assess catheter positioning, stability, and functionality in patient-specific anatomies.
Cannulas
Simulate insertion and flow dynamics within patient-specific vascular or cardiac anatomy, which enhances precision in cannula sizing, placement, and functionality for critical care.
Stents
Virtually test deployment, expansion, and arterial wall interaction in individualized vascular models.
Our end-to-end digital twin solution
Virtonomy’s virtual trial platform supports the full product life cycle of medical device development, from concept phase to regulatory reporting and clinical practice
Thousands of Virtual Patients
- Virtual patient cohort tailored for you
- Advanced 3D visualization and interactive implantation
- Accurate 3D measurements and extensive statistics
Advanced Statistical Shape Models
- Worst and edge-case anatomies
- Average patient anatomy
- Available for any customer-chosen patient group
Advanced Anatomical Simulations
- Validated ISO benchtop test simulations
- Validated in-human implant simulations
- You control the simulations, we take care of all difficulties
Regulatory Services & Consultation
- Regulatory path with a virtual testing plan
- Compliance with all regulatory bodies
- Validated virtual evidence report
Use our software in any stage of your development – from early design concept up to clinical use.
Benefits of using digital twins
Streamline development
Optimize your device using advanced anatomical studies and simulations and shorten the iteration loop from years to weeks.
Reduce costs and the risk to fail
Test early for a comparably low price in (virtual) humans and ensure product safety & performance prior to and after clinical trials
Ensure clinical trial success
Perform anatomical analysis and simulations for many patients to ensure the optimal design and maximize population coverage
Understanding patient anatomies and optimizing anatomical fit directly impacts the fate of development projects. Virtonomy’s combined expertise in specific pathologies, device/patient interactions and state of the art therapy options is tremendously valuable for anyone looking to create or optimize cardiovascular technologies.
Dr. Maximilian Kütting
Director R&D New Valve Technology
Use virtual patients as digital evidence for submission to regulatory bodies
The FDA and European Commission show strong support for virtual patients and simulation.
FDA’s Office of Science and Engineering Laboratories (OSEL) has committed significant resources for transforming computational modeling from a valuable scientific tool to a valuable regulatory tool because of its potential for significant cost-savings in evaluating medical devices, simulating performance under scenarios that may not be possible with human use or that could more effectively be evaluated with simulation.
Want us to help you draft a virtual testing plan?
Ask our regulatory experts to establish your virtual testing plan connected to your physical testing. We provide this service for free during a special workshop tailored to you. Learn about the new FDA guidance documents and ASME standards for Computational Modeling and Simulation. Our experts will highlight how you can apply them and streamline your regulatory process.
Latest from our blog
-
Debunking Myths: What’s Holding Back In Silico Innovation in Cardiovascular Devices
As regulatory frameworks evolve and digital health technologies advance, in silico methods like modeling, simulation, and virtual clinical trials are increasingly positioned to transform cardiovascular device development. In silico clinical trials for cardiovascular devices are high on the list of priorities for regulators such as FDA. Still, despite clear advantages, … Debunking Myths: What’s Holding…
-
How Digital Twins Are Transforming Healthcare
Key Insights from the Digital.Health Webinar Digital twin technology is rapidly reshaping the healthcare landscape, offering new ways to optimize medical treatments, device development, and patient care. In a recent Digital.Health webinar, industry experts, including Ami Bhatt (Chief Innovation Officer at American College of Cardiology), Simon Sonntag (Co-Founder & CEO … How Digital Twins Are…
See our platform
v-Patients in action
Get a demo and see how our customers use v-Patients to speed up their device development and save costs.